Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Sets Key Dates for 25% Preferred Stock Dividend
Via Investor Brand Network
Tickers BMWYY NTRB
Exposures Product Safety
GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning
Via Benzinga
Tickers GSK
Exposures Product Safety
Dow Futures Edge Higher As Strong Earnings Boost Investor Confidence: AXP, NFLX, IBKR, GSK Among Stocks To Watch
Via Stocktwits
Topics ETFs Economy Government
Tickers AXP GSK IBKR IVZ
Exposures Economy Political Product Safety
BrainStorm Cell Therapeutics Crashes After Hours On Nasdaq Delisting Notice; Retail Sees 'Buy Time'
Via Stocktwits
Tickers BCLI
Exposures Product Safety
GSK’s Blenrep Underwhelms FDA Panel Over Dose Risk-Benefit Balance In Myeloma; Retail Traders Stay Optimistic
Via Stocktwits
Tickers GSK
Exposures Product Safety
Trading Radar For July 18: RIL, Wipro, Axis Bank, Vedanta, Jio Financial And Lupin Are On The Watchlist
Via Stocktwits
Tickers TTM
Exposures Product Safety
Sarepta Therapeutics' Reorganization Boosts Investor Confidence
Via Benzinga
Tickers SRPT
Exposures Product Safety
Shareholders of Rocket Pharmaceuticals, Inc. Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Shareholders of Rocket Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Receives MHRA Approval to Launch Second Phase 3 Trial for CYB003 in Depression
Via Investor Brand Network
Tickers CYBN
Exposures Product Safety
Ainnova Tech Reaches Major FDA Milestone in AI-Powered Diabetic Retinopathy Detection
Via AB Newswire
Topics Artificial Intelligence
Tickers AVAI
Exposures Artificial Intelligence Product Safety
Is Johnson & Johnson a Good Dividend Stock to Buy Now?
Via The Motley Fool
Tickers JNJ
Exposures Product Safety
Sarepta Surges After-Hours As It Slashes 500 Jobs Amid FDA Black Box Warning For Gene Therapy — Retail Eyes Rebound
Via Stocktwits
Topics Death
Tickers SRPT
Exposures Death Product Safety
The Man Who Listens to Bodies: Vadim Borisov’s Unlikely Journey from Soviet Classroom to Global Wellness Stage
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Why Ford (F) Stock Is Trading Lower Today
Via StockStory
Topics Product Recall
Tickers F
Exposures Legal Product Safety
Remembering the Distomo Tragedy: Sehremelis Recalls His Family’s Survival
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Suit Seeking Recovery - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Not Just a Patch Earns FDA, EU Clearance for CGM Patches Line, Expanding Diabetes Support Offerings
Via Press Release Distribution Service
Tickers MDT
Exposures Product Safety
PsychedelicNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
FDA Lifts Pause On Kezar's Liver Drug Trial—Next Stop Lupus Study
Via Benzinga
Tickers KZR
Exposures Product Safety
Medicus Pharma Ltd. (NASDAQ:MDCX): Novel Pipeline Presents Unique Opportunity To Capitalize On Rare Disease Market Worth Over $15 Billion
Via News Direct
Topics Government World Trade
Tickers MDCX
Exposures Political Product Safety Tariff
From Phase 2 Trial Results To Expansion Mode: A Look At BioRestorative's Novel Approach To Treating Chronic Pain
Via NewMediaWire
Tickers BRTX
Exposures Product Safety
From Phase 2 Trial Results To Expansion Mode: A Look At BioRestorative's Novel Approach To Treating Chronic Pain
Via TheNewswire.com
Tickers BRTX
Exposures Product Safety
Dow Health Giant J&J Surges After Hiking Outlook On Strong Quarterly Report
Via Investor's Business Daily
Topics Stocks
Tickers JNJ
Exposures Product Safety US Equities
Medicus Pharma Ltd. (NASDAQ:MDCX): Novel Pipeline Presents Unique Opportunity To Capitalize On Rare Disease Market Worth Over $15 Billion
Via AB Newswire
Topics Government World Trade
Tickers MDCX
Exposures Political Product Safety Tariff
Buy Biocon, Zydus Life For Short-Term Gains, Says SEBI RA Vinayak Gautam After Fresh Regulatory Approvals
Via Stocktwits
Tickers INTC
Exposures Product Safety
Trading Radar For July 16: ICICI Lombard, Dixon, Biocon, Zydus And HDFC Life Are Among The Stocks To Watch
Via Stocktwits
Exposures Product Safety
Fresh Healthcare Launches New Website and TikTok Shop to Enhance Customer Experience
Via Press Release Distribution Service
Tickers AAPL
Exposures Product Safety
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.